Imprivata UK and JAC Medicines Management deliver fast, secure signing for drug administration Wednesday 28 September 2016 PDF Print we have improved visibility and a more complete audit trail for prescribing, administering, and disposing of controlled drugs Imprivata Confirm ID integrates with JAC Electronic Prescribing and Medicine Administration system to enable fast, secure user authentication for medication lifecycle workflows to improve efficiency and auditing London, England —Imprivata®, the healthcare IT security company, today announced that Imprivata Confirm ID™, the comprehensive identity and multifactor authentication platform for healthcare, integrates with JAC Medicines Management electronic prescribing system to improve security, auditing, and efficiency of medication lifecycle workflows. Imprivata Confirm ID for Clinical Workflows enables fast, secure authentication within the JAC Electronic Prescribing and Medicines Administration (EPMA) system, including for witness signing for drug administering and other workflows. The integrated solution simplifies user authentication, improves efficiency and auditing, and saves time while also strengthening security. Imprivata Confirm ID allows users to simply tap a proximity card to authenticate within the JAC EPMA system, replacing the manual entry of user name and passwords, which are often complex and can be easily forgotten. Imprivata Confirm ID gives care providers a fast and convenient workflow, enabling strong authentication and delivering a seamless, consistent user experience. “Good cyber hygiene isn’t just about protecting systems from harm, it’s about enabling technological leaps that help to improve patient outcomes and deliver proactive care management,” commented Dr. Saif Abed, Medical Director EMEA at Imprivata. “The Imprivata Confirm ID integration with JAC EPMA makes security invisible to users, improving security and compliance without compromising efficiency or the delivery of patient care.” Imprivata Confirm ID is part of the Imprivata Authentication and Access Management platform, which includes Imprivata OneSign®, healthcare’s leading enterprise single sign-on (SSO) solution, and enables healthcare organisations to securely and conveniently access and transact patient information both inside and outside of the hospital. Imprivata Confirm ID for Clinical Workflows combines security and convenience by enabling fast, consistent authentication whilst improving visibility into all user interactions with patient records, hospital financial data, and other sensitive information across all enterprise workflows. This delivers an auditable trail enabling organisations to meet important governance requirements and reduce the risks of information loss. Grant Harris, Director of IT at Western Sussex Hospital NHS Foundation Trust stated; “Imprivata has helped us optimise our use of the JAC system by improving efficiencies for clinicians and enabling fast, convenient authentication for witness signing. Enabling these automated workflows with the same process we have for SSO delivers a consistent, familiar workflow for accessing workstations and applications as well as for the re-authentication workflows within the JAC system. Not only has this driven adoption, but we have improved visibility and a more complete audit trail for prescribing, administering, and disposing of controlled drugs.” The JAC EPMA and Imprivata Confirm ID for Clinical Workflows integration will be on show for the first time at Healthcare Efficiency through Technology (HETT), on 28 September 2016, Olympia, London, on stand numbers: H398 for Imprivata and H404 for JAC. http://www.hettshow.co.uk/exhibitor/imprivata-2/ To learn more about Imprivata Confirm ID, visit; www.imprivata.co.uk/uk/imprivata-confirm-id -ends- NOTES TO EDITORS About JAC JAC is the UK's leading medicine management systems specialist, with the largest installed base of EPMA systems in UK hospitals. With over 35 years' experience within medicines management, JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services and third-party interfaces. JAC's systems are used in more than half of all NHS trusts in England as well as sites in Jersey, Scotland, Wales, Northern Ireland, Ireland, Norway and South Africa. In May 1996, JAC was acquired by Mediware Inc and continues to operate as a wholly owned subsidiary. The acquisition by Mediware Inc created the world's largest supplier of medicines management systems for hospital pharmacies. For more information about JAC products and services, visit our website at JAC About Imprivata Imprivata®, the healthcare IT security company, provides healthcare organisations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. On 16 September 2016, Imprivata was acquired by leading private equity investment firm Thoma Bravo, LCC. Imprivata security solutions are used by the vast majority of hospitals in the UK. For more information please visit: Imprivata Press Contacts Frank Lampe Marketing Director EMEA & APAC Imprivata +49 (0)421 17 50 242 email@example.com Andreina West/Mary Phillips PR Artistry +44 (0) 1491 639500 email: firstname.lastname@example.org This press release was distributed by ResponseSource Press Release Wire on behalf of PR Artistry in the following categories: Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.